[Scintigraphic control of bone metastases of prostatic cancer treated with cytonal and cyclophosphamide].
Grossmann
J
J
Weiss
M
M
Deckart
H
H
Raatzsch
H
H
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000556:secondary*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004054:Diethylstilbestrol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004338:Drug Combinations; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy; D011877:Radionuclide Imaging; D013669:Technetium Tc 99m Medronate
D000970:Antineoplastic Agents; D004338:Drug Combinations; D004054:Diethylstilbestrol; D003520:Cyclophosphamide; C004955:fosfestrol; D013669:Technetium Tc 99m Medronate
Szintigraphische Kontrolle von Skelettmetastasen unter Cytonal-, Cyclophosphamidtherapie bei Prostatakarzinom.